Abstract
The ubiquitous involvement of key iron-containing metalloenzymes in metabolism is reflected in the dependence of virtually all bacteria on iron for growth and, thereby, potentially provides multiple biomolecular targets for antimicrobial killing. We hypothesized that nitrosative stress, which induces damage to iron metalloproteins, would sensitize bacteria to the ferric iron mimic gallium(III) (Ga3+), potentially providing a novel therapeutic combination. Using both laboratory and clinical isolates of Pseudomonas aeruginosa, we herein demonstrate that Ga3+ and sodium nitrite synergistically inhibit bacterial growth under both aerobic and anaerobic conditions. Nitric oxide also potentiated the antimicrobial effect of Ga3+. Because many chronic pulmonary infections are found as biofilms and biofilms have very high antibiotic tolerance, we then tested the combination against biofilms grown on plastic surfaces, as well as the apical surface of airway epithelial cells. Ga3+ and sodium nitrite had synergistic antimicrobial activity against both biofilms grown on plastic and on airway epithelial cell. Both Ga3+ and various NO donors are (independently) in clinical development as potential antimicrobials, however, we now propose the combination to have some particular advantages, while anticipating it should ultimately prove similarly safe for translation to treatment of human disease.
Highlights
Antibiotic resistance, especially in relation to the management of nosocomial infections, continues to be a growing problem worldwide
Anaerobic growth, such as that found in the cystic fibrosis (CF) lung, causes increased antimicrobial tolerance as well as reliance on alternative metabolic pathways which may have different sensitives to inhibition by Ga3+ and nitrite (Alvarez-Ortega and Harwood, 2007; Arai, 2011; Schaible et al, 2012)
The anaerobic nitrite Minimum Inhibitory Concentrations (MICs) was 5 mM for both strains and, again, synergy was seen for both strains (Figure 1B)
Summary
Antibiotic resistance, especially in relation to the management of nosocomial infections, continues to be a growing problem worldwide. This matter is of some particular concern in the treatment of chronic suppurative lung diseases such as cystic fibrosis (CF). Pseudomonas aeruginosa is the most common Gram-negative pathogen in adults with CF, and decades of antibiotic exposure leads to acquired antibiotic resistance in addition to the high innate antibiotic resistance of the organism (Patient Registry, 2011). Beyond its prominence in CF, P. aeruginosa is one of the ESKAPE pathogens, causing a variety of respiratory infections and chronic wound infections, including those at surgical sites, that can be recalcitrant to treatment (Rice, 2010; Mulani et al, 2019). There is clearly an ongoing need for the development of new antimicrobial approaches toward P. aeruginosa.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.